pyrazolanthrone has been researched along with dinoprostone in 14 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 7 (50.00) | 29.6817 |
2010's | 7 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Busse, R; Fleming, I; Kohlstedt, K | 1 |
Goldring, MB; Jalonen, U; Kankaanranta, H; Lahti, A; Leinonen, S; Moilanen, E; Nieminen, R; Vuolteenaho, K | 1 |
Jalonen, U; Kankaanranta, H; Lahti, A; Moilanen, E; Nieminen, R | 1 |
Ashizuka, M; Ito, S; Kubota, Y; Ogata, S; Satoh, S; Shirasuna, K; Takeuchi, H | 1 |
Bachelet, M; Bardin, S; Broquet, AH; Gasnereau, I; Jouniaux, AM; Lenoir, C; Masliah, J; Sapin, C; Seksik, P; Thomas, G; Trugnan, G | 1 |
Chang, DM; Ho, LJ; Hou, TY; Hung, LF; Lai, JH; Liang, CC; Lin, LC; Wang, SJ | 1 |
Han, X; Lin, Y; Luo, Y; Lv, J; Meng, Z; Nie, J; Sun, Y; Yang, T; Zhu, Y | 1 |
Chung, HT; Jeong, GS; Kim, EC; Kim, YS; Lee, SK; Oh, HW; Pae, HO; Pi, SH | 1 |
Aso, H; Hasegawa, Y; Imaizumi, K; Ito, S; Kondo, M; Mori, A; Morioka, M; Suganuma, N | 1 |
Chang, JZ; Chen, HM; Deng, YT; Kuo, MY; Yang, WH | 1 |
Arancibia, R; Martínez, J; Maturana, C; Salazar, JC; Silva, D; Smith, PC; Tapia, C; Tobar, N | 1 |
Kondo, A; Kozawa, O; Kuroyanagi, G; Matsushima-Nishiwaki, R; Mizutani, J; Otsuka, T; Tokuda, H; Yamamoto, N | 1 |
Ashley, AK; Hanneman, WH; Hinds, AI; Legare, ME; Tjalkens, RB | 1 |
14 other study(ies) available for pyrazolanthrone and dinoprostone
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Signaling via the angiotensin-converting enzyme enhances the expression of cyclooxygenase-2 in endothelial cells.
Topics: 6-Ketoprostaglandin F1 alpha; Amino Acid Substitution; Angiotensin-Converting Enzyme Inhibitors; Animals; Anthracenes; Aorta; Binding, Competitive; Celecoxib; Cells, Cultured; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dinoprostone; DNA; Endothelial Cells; Endothelium, Vascular; Enzyme Induction; Humans; JNK Mitogen-Activated Protein Kinases; Lung; Male; Membrane Proteins; Mice; Mice, Inbred C57BL; Mutation, Missense; Oligodeoxyribonucleotides; Peptidyl-Dipeptidase A; Phosphorylation; Promoter Regions, Genetic; Prostaglandin-Endoperoxide Synthases; Prostaglandins I; Protein Processing, Post-Translational; Pyrazoles; Ramipril; Recombinant Fusion Proteins; Signal Transduction; Sulfonamides; Sus scrofa; Thromboxane A2; Transcription Factor AP-1; Transcription, Genetic; Transfection; Umbilical Veins | 2005 |
Inhibitors of mitogen-activated protein kinases downregulate COX-2 expression in human chondrocytes.
Topics: Anthracenes; Chondrocytes; Cyclooxygenase 2; Dinoprostone; Dose-Response Relationship, Drug; Down-Regulation; Enzyme Activation; Enzyme Inhibitors; Flavonoids; Gene Expression Regulation, Enzymologic; Humans; Imidazoles; Interleukin-1; Mitogen-Activated Protein Kinases; Pyridines; RNA, Messenger; Signal Transduction | 2005 |
JNK inhibitor SP600125 reduces COX-2 expression by attenuating mRNA in activated murine J774 macrophages.
Topics: Animals; Anthracenes; Benzazepines; Cell Line; Cyclin-Dependent Kinase 2; Cycloheximide; Cyclooxygenase 2; Dactinomycin; Dinoprostone; Dose-Response Relationship, Drug; Gene Expression Regulation, Enzymologic; Indoles; JNK Mitogen-Activated Protein Kinases; Lipopolysaccharides; Macrophages; Mice; Oximes; Phosphorylation; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-jun; RNA, Messenger; Transcription, Genetic | 2006 |
Ca2+ stimulates COX-2 expression through calcium-sensing receptor in fibroblasts.
Topics: Anthracenes; Bone and Bones; Calcium; Calcium Signaling; Cations, Divalent; Cyclooxygenase 2; Dinoprostone; Estrenes; Fibroblasts; Flavonoids; Humans; Imidazoles; Mitogen-Activated Protein Kinases; Phosphorylation; Protein Kinase Inhibitors; Pyridines; Pyrrolidinones; Receptors, Calcium-Sensing; RNA, Messenger; Type C Phospholipases | 2006 |
MD-2 controls bacterial lipopolysaccharide hyporesponsiveness in human intestinal epithelial cells.
Topics: Anthracenes; Caco-2 Cells; Cell Line, Tumor; Cells, Cultured; Cyclooxygenase 2; Dinoprostone; Dose-Response Relationship, Drug; Enzyme Inhibitors; Epithelial Cells; Flow Cytometry; Gene Expression; HT29 Cells; Humans; Imidazoles; Interleukin-8; Intestines; Lipopolysaccharides; Lymphocyte Antigen 96; Mitogen-Activated Protein Kinases; Monocytes; NF-kappa B; Pyridines; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Toll-Like Receptor 4; Transfection | 2008 |
Retinoid acid inhibits IL-1-induced iNOS, COX-2 and chemokine production in human chondrocytes.
Topics: Anthracenes; Cell Line; Chemokines; Chondrocytes; Cyclooxygenase 2; Dinoprostone; Humans; Interleukin-1; MAP Kinase Kinase 4; Nitric Oxide Synthase Type II; Transcription Factor AP-1; Tretinoin | 2008 |
Forkhead box O1/pancreatic and duodenal homeobox 1 intracellular translocation is regulated by c-Jun N-terminal kinase and involved in prostaglandin E2-induced pancreatic beta-cell dysfunction.
Topics: Animals; Anthracenes; Blotting, Western; Cell Line; Dinoprostone; Forkhead Box Protein O1; Forkhead Transcription Factors; Glucose; Homeodomain Proteins; Insulin; Insulin Secretion; Insulin-Secreting Cells; JNK Mitogen-Activated Protein Kinases; Luciferases; Mice; Mice, Inbred ICR; Microscopy, Fluorescence; Phosphorylation; Protein Transport; Proto-Oncogene Proteins c-akt; Recombinant Fusion Proteins; Trans-Activators; Transfection | 2009 |
Heme oxygenase-1 mediates nicotine- and lipopolysaccharide-induced expression of cyclooxygenase-2 and inducible nitric oxide synthase in human periodontal ligament cells.
Topics: Androstadienes; Anthracenes; Cell Line; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Dinoprostone; Enzyme Inhibitors; Heme Oxygenase-1; Humans; Inflammation Mediators; JNK Mitogen-Activated Protein Kinases; Lipopolysaccharides; Metalloporphyrins; NF-kappa B; Nicotine; Nitric Oxide; Nitric Oxide Synthase Type II; Periodontal Ligament; Phosphoinositide-3 Kinase Inhibitors; Protoporphyrins; RNA, Small Interfering; Transfection; Wortmannin | 2010 |
Prostaglandin E2 enhances interleukin-8 production via EP4 receptor in human pulmonary microvascular endothelial cells.
Topics: Acute Lung Injury; Anthracenes; Butadienes; Cells, Cultured; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Cyclooxygenase 1; Cyclooxygenase 2; Dinoprostone; Endothelial Cells; Humans; Imidazoles; Interleukin-8; JNK Mitogen-Activated Protein Kinases; Lung; MAP Kinase Signaling System; Methyl Ethers; Microvessels; Naphthalenes; Neutrophils; Nitriles; p38 Mitogen-Activated Protein Kinases; Phenylbutyrates; Pyridines; Receptors, Prostaglandin E, EP4 Subtype; Respiratory Distress Syndrome; RNA, Messenger; Thionucleotides | 2012 |
EGCG blocks TGFβ1-induced CCN2 by suppressing JNK and p38 in buccal fibroblasts.
Topics: Anthracenes; Benzamides; Catechin; Cell Line; Cells, Cultured; Connective Tissue Growth Factor; Dinoprostone; Dioxoles; Dose-Response Relationship, Drug; Fibroblasts; Flavonoids; Humans; Imidazoles; Lung; MAP Kinase Kinase 4; Mouth Mucosa; Oral Submucous Fibrosis; p38 Mitogen-Activated Protein Kinases; Protease Inhibitors; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Pyridines; Receptor, Transforming Growth Factor-beta Type I; Receptors, Transforming Growth Factor beta; Transforming Growth Factor beta1 | 2013 |
Effects of chitosan particles in periodontal pathogens and gingival fibroblasts.
Topics: Adult; Aggregatibacter actinomycetemcomitans; Anthracenes; Anti-Bacterial Agents; Anti-Inflammatory Agents; Bacteriological Techniques; Cell Survival; Cells, Cultured; Chitosan; Dinoprostone; Fibroblasts; Gingiva; Humans; Indicators and Reagents; Interleukin-1beta; JNK Mitogen-Activated Protein Kinases; L-Lactate Dehydrogenase; MAP Kinase Signaling System; Nanoparticles; NF-kappa B; Periodontal Diseases; Phosphorylation; Porphyromonas gingivalis; Signal Transduction; Tetrazolium Salts; Thiazoles; Transcription Factor RelA | 2013 |
Regulation by resveratrol of prostaglandin E2-stimulated osteoprotegerin synthesis in osteoblasts.
Topics: 3T3 Cells; Animals; Anthracenes; Dinoprostone; Imidazoles; JNK Mitogen-Activated Protein Kinases; Mice; Mitogen-Activated Protein Kinase 1; Osteoblasts; Osteoprotegerin; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Pyridines; Resveratrol; Sirtuin 1; Stilbenes | 2014 |
DJ-1 mutation decreases astroglial release of inflammatory mediators.
Topics: Animals; Anthracenes; Astrocytes; Butadienes; Cyclooxygenase 2; Dinoprostone; Imidazoles; Inflammation Mediators; Lipopolysaccharides; Mice; Mice, Knockout; Nitric Oxide; Nitric Oxide Synthase Type II; Nitriles; Primary Cell Culture; Protein Deglycase DJ-1; Pyridines; Tumor Necrosis Factor-alpha | 2016 |